Allakos's average Accounts Receivable for the
three
months ended in Mar. 2024 was $0.00 Mil. Allakos's Revenue for the
three
months ended in Mar. 2024 was $0.00 Mil.
The historical rank and industry rank for Allakos's Days Sales Outstanding or its related term are showing as below:
ALLK's Days Sales Outstanding is not ranked *
in the Biotechnology industry.
Industry Median: 72.665 * Ranked among companies with meaningful Days Sales Outstanding only.
Allakos's Days Sales Outstanding
stayed the same
from Mar. 2023 (0.00) to Mar. 2024 (0.00).
Allakos Days Sales Outstanding Historical Data
The historical data trend for Allakos's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Allakos's Days Sales Outstanding
For the Biotechnology subindustry, Allakos's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Allakos's Days Sales Outstanding Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Allakos's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Allakos's Days Sales Outstanding falls into.
Allakos Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Allakos (NAS:ALLK) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Allakos Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Allakos's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK002, an antibody that targets Siglec-8, an inhibitory receptor found on eosinophils and mast cells. In preclinical and clinical studies, AK002 has been shown to deplete eosinophils and inhibit mast cells.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ALLK has been successfully added to your 